United States · FDA National Drug Code directory
Xipere
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 24208-040_40a863fe-f804-71ae-e063-6294a90af8fa
- Product NDC
- 24208-040
- Form
- INJECTION, SUSPENSION
- Composition / generic term
- triamcinolone acetonide
- Labeler
- Bausch & Lomb Incorporated
- Marketing category
- NDA
- Marketing start / end (source format)
- 20211217
- Source listing expiry
- 20261231
Source-listed ingredients
- TRIAMCINOLONE ACETONIDE — 40 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 TRAY in 1 CARTON (24208-040-01) / 1 VIAL in 1 TRAY / .9 mL in 1 VIAL (24208-040-02) · 24208-040-01
- 1 TRAY in 1 CARTON (24208-040-40) / 1 VIAL in 1 TRAY / .9 mL in 1 VIAL (24208-040-41) · 24208-040-40
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →